Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > Audited results deadline Feb 28

<< Previous

Bullboard Posts

Next >>

Post by lscfaon Feb 27, 2024 3:06pm

108 Views

Post# 35902132

Audited results deadline Feb 28

Will there be any revenues?

Qtr ending	Milestone Payment	Sales to RF/Abbvie	Other	Total Revenue
Oct 23				0
Jul 23	0	6,815		6,815
Apr 23	0	59,514		59,514
Jan 23	0	0		0
Oct 22	0	18,055		18,055
Jul 22	640,000	13,868		653,868
Apr 22	0	0		0
Jan 22	0	0		0
Oct 21	0	29,900		29,900
Jul 21	0	29,040		29,040
Apr 21	0	190,923		190,923
Jan 21	0	18,159		18,159
Oct 20	67,225	38,486		105,711
Jul 20	0	0		0
Apr 20	0	0		0
Jan 20	0	0		0
Oct 19	67,225	0	68,518	135,743
Jul 19	0	0		0
Apr 19	0	0		0
Jan 19	0	0	64,500	64,500